4.7 Review

Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome

Yuanxia Lv et al.

Summary: CRF is a 41-amino acid polypeptide that coordinates various systems in the body, mediating visceral hypersensitivity like in irritable bowel syndrome. However, the lack of sufficient understanding of the multiple variants of CRF-R1 and CRF-R1 antagonists hinders the successful translation of preclinical studies into clinical trials. Investigating the sites of action of central and peripheral CRF is crucial for accelerating this translation process.

PEPTIDES (2022)

Review Gastroenterology & Hepatology

Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome

Eline Margrete Randulff Hillestad et al.

Summary: This comprehensive review discusses the major features of irritable bowel syndrome and its interaction with gut microbiota, clinical microbiota-altering treatments such as low FODMAP diet and fecal microbiota transplantation, neuroimaging and microbiota analysis methods, and current and future challenges in big data analysis in IBS.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Article Immunology

Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs

Pu Song et al.

Summary: This study investigated the effect of Candidalysin on mast cell (MC) activation and the underlying molecular mechanism. The results showed that Candidalysin enhanced MC degranulation, migration, and production of cytokines, eicosanoids, and reactive oxygen species. Additionally, Candidalysin increased the expression of Dectin-1, and inhibiting Dectin-1 reduced MC activation.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Immune regulation by fungal strain diversity in inflammatory bowel disease

Xin Li et al.

Summary: The study reveals the rich genetic diversity of pathogenic Candida albicans strains in the colonic mucosa of patients with inflammatory bowel disease, with some strains having high immune-cell-damaging capacity (HD strains). These strains exacerbate intestinal inflammation in vivo through specific mechanisms, highlighting new insights into host-fungal interactions and potential diagnostic and therapeutic targets for inflammatory diseases.

NATURE (2022)

Article Multidisciplinary Sciences

Environmental factors shaping the gut microbiome in a Dutch population

R. Gacesa et al.

Summary: This study analyzed the gut microbiome of 8,208 individuals from the Netherlands and found that the microbiome is primarily shaped by the environment and cohabitation. Only about 6.6% of microbial taxa are heritable, while around 48.6% of taxa are significantly influenced by cohabitation. Additionally, the study identified numerous associations between the microbiome and health, diet, socioeconomic factors, and early-life and current exposome.

NATURE (2022)

Article Multidisciplinary Sciences

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome

Isabelle A. M. van Thiel et al.

Summary: Irritable bowel syndrome (IBS) is a common disorder characterized by chronic abdominal pain and changes in bowel movements. Visceral hypersensitivity may be caused by intestinal fungi, but the diversity of fungal communities does not differ between IBS subgroups. The study highlights the importance of conducting strain-specific cause-and-effect studies in IBS research.

SCIENTIFIC REPORTS (2022)

Review Gastroenterology & Hepatology

Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome

Maria Rosa Ingrosso et al.

Summary: This study aimed to evaluate the efficacy and safety of peppermint oil in the treatment of IBS. The results showed that peppermint oil was more effective than placebo, but adverse events occurred more frequently.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Review Endocrinology & Metabolism

Low FODMAP diet in irritable bowel syndrome: a review of recent clinical trials and meta-analyses

Kevin Whelan et al.

Summary: The low FODMAP diet is widely used for the dietary management of irritable bowel syndrome (IBS). Recent clinical trials and meta-analyses have shown that the diet can effectively alleviate global symptoms of IBS in the short term. Long-term studies have also demonstrated symptom relief in at least 50% of individuals. Mechanisms of this diet's effectiveness include colonic gas production, altered gastrointestinal integrity, and changes in microbiome composition and function.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2022)

Review Gastroenterology & Hepatology

From intestinal colonization to systemic infections: Candida albicans translocation and dissemination

Jakob L. Sprague et al.

Summary: This review focuses on the mechanisms of fungal translocation of Candida albicans from the intestine into the bloodstream that leads to systemic infections. It compares the differences between enteric bacterial pathogens and C. albicans, while discussing various hypotheses for how C. albicans enters and disseminates through the bloodstream following translocation.

GUT MICROBES (2022)

Review Gastroenterology & Hepatology

Bacterial-fungal metabolic interactions within the microbiota and their potential relevance in human health and disease: a short review

Alexia Lapiere et al.

Summary: The composition of the microbiota has a significant impact on host health. Interactions between bacterial and fungal communities through metabolites play a role in shaping the microbial community.

GUT MICROBES (2022)

Article Food Science & Technology

Update of the list of QPS-recommended microbiological agents intentionally added to food or feed as notified to EFSA 16: suitability of taxonomic units notified to EFSA until March 2022

Kostas Koutsoumanis et al.

Summary: The qualified presumption of safety (QPS) approach provides a generic pre-evaluation of the safety of microorganisms in the food or feed chains. This assessment is regularly updated and supports the work of EFSA's Scientific Panels. The evaluation identified various microorganisms, but none of them were recommended for QPS status due to safety concerns or limited knowledge.

EFSA JOURNAL (2022)

Article Pharmacology & Pharmacy

Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome

Joost P. Algera et al.

Summary: Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction that affects 4% of the world's population. The pathophysiology of IBS is not fully understood, but recent studies have highlighted the importance of the gut microbiota and its potential role in alleviating gastrointestinal symptoms.

CURRENT OPINION IN PHARMACOLOGY (2022)

Review Food Science & Technology

Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome

Ao Liu et al.

Summary: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that significantly affects personal health and imposes a substantial economic burden on society. Emerging evidence suggests that IBS is associated with gut microbial dysbiosis, including not only bacteria but also fungi, viruses, archaea, and other parasitic microorganisms. Fungi and methanogens play a role in diagnosis and treatment of IBS.

TOXINS (2022)

Review Medicine, Research & Experimental

Fungal microbiome in inflammatory bowel disease: a critical assessment

David M. Underhill et al.

Summary: The gut microbiome, specifically the fungal community, plays a crucial role in the development and progression of inflammatory bowel disease (IBD). Recent studies have identified a strong association between certain fungal taxa and the cellular and molecular pathways of IBD. Furthermore, it has been found that disease-contributing bacteria and fungi may interact indirectly through their fungal-bacterial ecological interactions. These insights and research strategies provide a foundation for including the fungal community in both basic and translational IBD research.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Gastroenterology & Hepatology

Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases

Iliyan D. Iliev et al.

Summary: The intestinal microbiota is composed of a variety of fungal and viral components in addition to bacteria, which interact with the immune system and impact human physiology. Studies have shown that alterations in fungal and viral species in the gut are associated with inflammatory and autoimmune diseases, with potential to activate host-protective immune pathways while also contributing to inflammatory bowel disease. Modernization and the COVID-19 pandemic have introduced humans to new fungi and viruses, the consequences of which remain unknown. Lessons learned from animal studies on common gut viruses and fungi shed light on their impacts on health and intestinal diseases.

GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Local immune response to food antigens drives meal-induced abdominal pain

Javier Aguilera-Lizarraga et al.

Summary: Research has shown that bacterial infection and toxins can trigger the production of specific dietary-antigen-specific IgE antibodies in mice, leading to increased visceral pain. Additionally, injecting food antigens into the rectosigmoid mucosa of patients with irritable bowel syndrome can induce local oedema and mast cell activation, revealing new possibilities for treating related abdominal pain disorders.

NATURE (2021)

Article Multidisciplinary Sciences

The fecal mycobiome in patients with Irritable Bowel Syndrome

A. Das et al.

Summary: Alterations in the gut mycobiome were found to be significantly different between patients with Irritable Bowel Syndrome (IBS) and control subjects, but not among clinical subtypes of IBS. The mycobiome changes were significantly associated with alterations in the bacteriome and metabolome, but did not show a link with dietary habits. Despite co-variation with bacterial components, the mycobiome presents limited therapeutic and diagnostic potential for IBS.

SCIENTIFIC REPORTS (2021)

Article Biotechnology & Applied Microbiology

Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients

Piero Sciavilla et al.

Summary: Studies on irritable bowel syndrome have mainly focused on the role of gut bacteria in modulating intestinal functions, but limited evidence suggests that gut fungal communities may also play a role. This study compared the gut microbiota of IBS patients with healthy subjects, revealing significant differences in microbial composition. The findings suggest a potential involvement of gut fungi in IBS.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Article Cell Biology

Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans

Selene Mogavero et al.

Summary: Candidalysin is a peptide toxin secreted by C. albicans causing epithelial damage. Specific fungal attributes are required for candidalysin delivery to host cell membranes. The toxin accumulates in invasion pockets created by invasive hyphae, as visualised using camelid nanobodies.

CELLULAR MICROBIOLOGY (2021)

Review Medicine, General & Internal

Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Lynne McFarland et al.

Summary: After screening 521 studies, 42 randomized controlled trials were included in this study, with 4 probiotics showing significant reduction in abdominal pain, particularly B. coagulans MTCC5260. Mild-moderate adverse events were reported in 51% of the trials, but none were more associated with the probiotics compared to controls.

ECLINICALMEDICINE (2021)

Review Gastroenterology & Hepatology

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

Nikita Hanning et al.

Summary: Barrier dysfunction is present in a significant proportion of adult and all pediatric IBS studies, especially in the IBS-D and PI-IBS subtype. The majority of studies indicated a positive association between loss of barrier function and symptoms such as abdominal pain and changes in the bowel function.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Review Genetics & Heredity

Yeasts as probiotics: Mechanisms, outcomes, and future potential

Swastik Sen et al.

FUNGAL GENETICS AND BIOLOGY (2020)

Article Gastroenterology & Hepatology

Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome

Leif Kyrre Berg et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action

Hans-Dieter Allescher et al.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2020)

Article Biochemistry & Molecular Biology

Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption

Aleksandra S. Chikina et al.

Article Gastroenterology & Hepatology

The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome

Yan Chi et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Medicine, General & Internal

Functional Gastrointestinal Disorders 2 Irritable bowel syndrome

Alexander C. Ford et al.

LANCET (2020)

Editorial Material Microbiology

Setting Up Home: Fungal Rules of Commensalism in the Mammalian Gut

Jigar V. Desai et al.

CELL HOST & MICROBE (2019)

Article Multidisciplinary Sciences

Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG

Camille Nina Allonsius et al.

SCIENTIFIC REPORTS (2019)

Review Gastroenterology & Hepatology

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2019)

Article Biochemistry & Molecular Biology

Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity

Jonathan A. Cohen et al.

Article Microbiology

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

Elena Roselletti et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Microbiology

The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome

Yu Gu et al.

FRONTIERS IN MICROBIOLOGY (2019)

Article Gastroenterology & Hepatology

Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway

Ying-Jie Li et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Gastroenterology & Hepatology

Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome

Giovanni Barbara et al.

GASTROENTEROLOGY (2019)

Review Microbiology

Candidalysin: discovery and function in Candida albicans infections

Julian R. Naglik et al.

CURRENT OPINION IN MICROBIOLOGY (2019)

Review Gastroenterology & Hepatology

Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis

M. Bashashati et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Article Gastroenterology & Hepatology

Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation

Elizabeth J. Videlock et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)

Article Multidisciplinary Sciences

CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi

Irina Leonardi et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

The ATP Transporter VNUT Mediates Induction of Dectin-1-Triggered Candida Nociception

Kenta Maruyama et al.

ISCIENCE (2018)

Review Medicine, General & Internal

Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis

Lynne V. McFarland et al.

FRONTIERS IN MEDICINE (2018)

Review Microbiology

Candida albicans cell-type switching and functional plasticity in the mammalian host

Suzanne M. Noble et al.

NATURE REVIEWS MICROBIOLOGY (2017)

Review Immunology

Fungi in the healthy human gastrointestinal tract

Heather E. Hallen-Adams et al.

VIRULENCE (2017)

Article Gastroenterology & Hepatology

The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS

Heidi M. Staudacher et al.

Article Biotechnology & Applied Microbiology

Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides

Camille N. Allonsius et al.

MICROBIAL BIOTECHNOLOGY (2017)

Review Microbiology

Host-microbe interactions: commensal fungi in the gut

Marissa J. Paterson et al.

CURRENT OPINION IN MICROBIOLOGY (2017)

Article Gastroenterology & Hepatology

The role of mast cells in functional GI disorders

Mira M. Wouters et al.

Article Multidisciplinary Sciences

Candidalysin is a fungal peptide toxin critical for mucosal infection

David L. Moyes et al.

NATURE (2016)

Article Multidisciplinary Sciences

Bacteria activate sensory neurons that modulate pain and inflammation

Isaac M. Chiu et al.

NATURE (2013)

Article Multidisciplinary Sciences

Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents

Christian Hoffmann et al.

PLOS ONE (2013)

Article Gastroenterology & Hepatology

Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship

Breg Braak et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

The absence of functional dectin-1 on enterocytes may serve to prevent intestinal damage

Julia J. Volman et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)

Article Multidisciplinary Sciences

A human gut microbial gene catalogue established by metagenomic sequencing

Junjie Qin et al.

NATURE (2010)

Article Dentistry, Oral Surgery & Medicine

Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study

Pamela Hasslof et al.

BMC ORAL HEALTH (2010)

Article Gastroenterology & Hepatology

Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?

Seth Sweetser et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)

Article Gastroenterology & Hepatology

Yeasts: Neglected Pathogens

Daniel Poulain et al.

DIGESTIVE DISEASES (2009)

Article Gastroenterology & Hepatology

Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats

R. M. van den Wijngaard et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2009)

Article Gastroenterology & Hepatology

Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients

A. M. Schoepfer et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2008)

Article Gastroenterology & Hepatology

Assessment of visceral sensitivity using radio telemetry in a rat model of maternal separation

O Welting et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2005)

Article Biochemistry & Molecular Biology

Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway

N Vergnolle et al.

NATURE MEDICINE (2001)